PublishedMay 22, 2019 Category Publications Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates.
PublishedMay 20, 2019 Category Partner News New Phase 3 Data Show Sustainability and Durability of Culture Conversion with ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with Refractory MAC Lung Disease
PublishedMay 15, 2019 Category Publications A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation.
PublishedMay 1, 2019 Category Partner News Sunovion to Present Data on LONHALA® MAGNAIR® Inhalation Solution and COPD at the American Thoracic Society International Conference 2019
PublishedMarch 26, 2019 Category Partner News Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome.